US Pharm. 2011;36(11):56. 

Prasco Laboratories, Cincinnati, Ohio, announced that it has signed a marketing and distribution agreement with Eli Lilly and Company to market the authorized generic version of Zyprexa (olanzapine) Tablets and Zyprexa Zydis (olanzapine) Orally Disintegrating Tablets in the U.S. Prasco will begin distributing both products when the first ANDA enters the market. Prasco will market all six strengths of Olanzapine Tablets 2.5 mg, 5 mg, 7.5 mg, 10 mg, 15 mg, and 20 mg. Olanzapine Orally Disintegrating Tablets will be available in 5-mg, 10-mg, 15-mg, and 20-mg strengths.